Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Saskia H. Hanemaaijer"'
Autor:
Saskia H. Hanemaaijer, Iris C. Kok, Rudolf S. N. Fehrmann, Bert van der Vegt, Jourik A. Gietema, Boudewijn E. C. Plaat, Marcel A. T. M. van Vugt, Marije R. Vergeer, C. René Leemans, Johannes A. Langendijk, Jens Voortman, Jan Buter, Sjoukje F. Oosting
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Chemoradiotherapy (CRT) including three cycles of cisplatin is considered the standard of care for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, around one-third of the patients cannot complete cisplatin beca
Externí odkaz:
https://doaj.org/article/41c85e17066d44cbaa8705b2b5208976
Autor:
Boudewijn E. C. Plaat, Max J. H. Witjes, Saskia H Hanemaaijer, Gyorgy B. Halmos, Bernard F. A. M. van der Laan, Jeroen E. van Schaik, Bert van der Vegt
Publikováno v:
Otolaryngology--Head and Neck Surgery
Otolaryngology-Head and Neck Surgery, 163(6), 1202-1208. SAGE Publications Inc.
Otolaryngology-Head and Neck Surgery, 163(6), 1202-1208. SAGE Publications Inc.
OBJECTIVE: To evaluate expression of potential molecular imaging targets epidermal growth factor receptor (EGFR), glycoprotein nonmetastatic melanoma protein B (GPNMB), and vascular endothelial growth factor (VEGF) in lymph nodes (LNs) with or withou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f72667b9ece5db7e04f1347e03161aba
https://doi.org/10.1177/0194599820932869
https://doi.org/10.1177/0194599820932869
Autor:
Max J. H. Witjes, Roel J H M Steenbakkers, Bart Dorgelo, Boudewijn E. C. Plaat, Maran Fazzi, Bernard F. A. M. van der Laan, Bert van der Vegt, Gilles N. Stormezand, Saskia H Hanemaaijer, Sjoukje F. Oosting
Publikováno v:
Clinical Otolaryngology, 45(5), 805-810. Wiley
Clinical Otolaryngology
Clinical Otolaryngology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7792e1c5df2307fb619955bfafb83fd
https://doi.org/10.1111/coa.13566
https://doi.org/10.1111/coa.13566
Autor:
Jeroen E. van Schaik, Bert van der Vegt, Saskia H. Hanemaaijer, Gyorgy B. Halmos, Max J. Witjes, Bernard F.A.M. van der Laan, Rudolf S. Fehrmann, Sjoukje F. Oosting, Boudewijn E. Plaat
Publikováno v:
Cancer Research. 82:6261-6261
Objective: To evaluate expression of the potential molecular imaging targets glycoprotein nonmetastatic melanoma protein B (GPNMB) and vascular endothelial growth factor (VEGF) in comparison to classical epidermal growth factor receptor (EGFR) in pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8422451ff93216164b2df9e8bcab79ef
https://doi.org/10.1158/1538-7445.am2022-6261
https://doi.org/10.1158/1538-7445.am2022-6261
Autor:
Boudewijn E. C. Plaat, Johannes A. Langendijk, Marcel A. T. M. van Vugt, Marije R. Vergeer, Sjoukje F. Oosting, Rudolf S N Fehrmann, Saskia H Hanemaaijer, Jourik A. Gietema, Iris C. Kok, Jan Buter, C. René Leemans, Jens Voortman, Bert van der Vegt
Publikováno v:
Hanemaaijer, S H, Kok, I C, Fehrmann, R S N, van der Vegt, B, Gietema, J A, Plaat, B E C, van Vugt, M A T M, Vergeer, M R, Leemans, C R, Langendijk, J A, Voortman, J, Buter, J & Oosting, S F 2020, ' Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma ', Frontiers in Oncology, vol. 10, 761 . https://doi.org/10.3389/fonc.2020.00761, https://doi.org/10.3389/fonc.2020.00761
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, 10:761. Frontiers Media SA
Frontiers in Oncology
Frontiers in Oncology, 10:761. Frontiers Media S.A.
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, 10:761. Frontiers Media SA
Frontiers in Oncology
Frontiers in Oncology, 10:761. Frontiers Media S.A.
Background: Chemoradiotherapy (CRT) including three cycles of cisplatin is considered the standard of care for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, around one-third of the patients cannot complete cisplatin beca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39ccbb3e7ae55bfd5c25461ff3b4163
https://research.vumc.nl/en/publications/f898cfe9-e838-4b4a-92b6-27f6d6319720
https://research.vumc.nl/en/publications/f898cfe9-e838-4b4a-92b6-27f6d6319720
Autor:
Boudewijn E. C. Plaat, Bert van der Vegt, Kirsten L. Moek, Marcel A. T. M. van Vugt, Saskia H Hanemaaijer, Stephanie E van Gijn, Jan L. N. Roodenburg, Ed Schuuring, Bernard F. A. M. van der Laan, Rudolf S N Fehrmann, Sjoukje F. Oosting
Publikováno v:
Oral Oncology, 80, 33-39. ELSEVIER SCIENCE BV
Background: For patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) palliative treatment options that improve overall survival are limited. The prognosis in this group remains poor and there is an unmet need for new th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd49542c754e6f3665c12f4b3f930778
https://research.rug.nl/en/publications/67c32e83-e472-4c3f-b4e1-71898d910c75
https://research.rug.nl/en/publications/67c32e83-e472-4c3f-b4e1-71898d910c75